Expansion into Urology: CHC Enhances Patient Care in Michigan

The Cancer & Hematology Centers Expands into Urology Specialty

The Cancer & Hematology Centers (CHC) of Michigan, known as the state's largest physician-owned oncology and hematology practice, has taken a significant step towards expanding its specialty services with the recent addition of urology care. This development is poised to enhance patient access to a wider array of health services, introducing a new level of comprehensive care that addresses both cancer and urological needs in the community.

On February 26, 2026, CHC announced the welcoming of two urologists, Dr. Rafid Yousif and Dr. Robert Dimitriou, both of whom previously practiced at the Lansing Institute of Urology. Their integration into the CHC team will allow them to provide urological services not only at their primary clinic in East Lansing but also across various physician offices in Mid-Michigan and Grand Rapids. The new urology services will operate under the name The Urology Institute, further solidifying CHC's commitment to community-based healthcare.

In conjunction with the urological team, CHC Lansing also welcomes two radiation oncologists, Dr. Edward Lee and Dr. Michael Cardenas, expanding the range of oncology services available. Dr. Lee formerly treated patients at Compass Cancer Center in Lansing, and along with Dr. Cardenas, will enhance CHC's capability to deliver well-coordinated care for patients navigating through the complexities of cancer treatment.

The introduction of these specialists signifies more than just an expansion of services; it symbolizes the creation of a holistic approach to patient care. By uniting urology, radiation oncology, and medical oncology within the independent practice's framework, CHC aims to deliver a seamless care experience. Dr. Yousif emphasized this integrated approach, stating that it allows patients to receive comprehensive care close to home, reducing the need for travel while ensuring they have access to all necessary specialties.

CHC's model of care has been fueled by its partnership with OneOncology, a nationwide physician services organization that supports a vast network of over 2,300 providers. This partnership enables community practices like CHC to thrive while offering high-quality specialty care. Research has indicated that care delivered in independent practices is often more cost-effective than similar services provided in hospital settings, ultimately benefiting patients economically.

Founded in Grand Rapids in 1979, the Cancer & Hematology Centers has nurtured a legacy of patient care that resonates throughout Michigan. With ten medical specialty clinics and a team of forty physicians, CHC is steadfast in its mission to provide innovative treatments and a therapeutic environment. Their services extend beyond simply treating cancer; they also include patient-centered approaches with programs in benign and malignant hematology, outpatient specialty pharmacy services, and access to clinical trials.

As the CHC continues to grow, it remains focused on enhancing its services with compassion and commitment to the community. In doing so, it aims to improve the lives of patients battling cancer and urological issues, fostering a collaborative care environment that prioritizes the well-being of each individual. With The Urology Institute, patients can now benefit from integrated care tailored to their specific needs, reinforcing the center’s dedication to providing cutting-edge, holistic healthcare solutions across the region.

For more information about The Cancer & Hematology Centers or The Urology Institute, you can visit their respective websites: The Cancer & Hematology Centers and The Urology Institute.